These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38883217)

  • 21. Bullous eczema presenting as bullous pemphigoid-like eruption: A case series.
    Atteh G; Cole EF; Perricone AJ; Feldman RJ
    JAAD Case Rep; 2021 Apr; 10():34-37. PubMed ID: 33732844
    [No Abstract]   [Full Text] [Related]  

  • 22. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
    Yasuda H; Tomita Y; Shibaki A; Hashimoto T
    Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of C4d immunohistochemical marker in the diagnosis of bullous pemphigoid: A cross-sectional study.
    Sneha Muppala R; Basavaraj V
    Indian J Dermatol Venereol Leprol; 2024; 90(5):569-574. PubMed ID: 38595011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual role of basophils in the pathogenesis of bullous pemphigoid elucidated by pathological and ultrastructural studies.
    Kimura R; Sugita K; Horie T; Yamamoto O
    Eur J Dermatol; 2022 May; 32(3):322-333. PubMed ID: 36065540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum soluble CD200 level was higher in patients with bullous pemphigoid during the active phase of the disease than for healthy individuals.
    Akman-Karakaş A; Yalcin AD; Koç S; Gumuslu S; Ergun E; Genc GE; Ongut G; Uzun S; Alpsoy E
    Clin Lab; 2014; 60(7):1237-40. PubMed ID: 25134396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
    Teraki Y; Hotta T; Shiohara T
    J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid.
    Gore Karaali M; Koku Aksu AE; Cin M; Leblebici C; Kara Polat A; Gurel MS
    Australas J Dermatol; 2021 May; 62(2):e236-e241. PubMed ID: 33748980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonbullous pemphigoid: A systematic review.
    Lamberts A; Meijer JM; Jonkman MF
    J Am Acad Dermatol; 2018 May; 78(5):989-995.e2. PubMed ID: 29102490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
    Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
    Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bullous pemphigoid sparing acquired lymphedema].
    Roguedas AM; Crespel E; Kupfer I; De Saint Martin L; Misery L; Sassolas B
    Ann Dermatol Venereol; 2006 Mar; 133(3):250-2. PubMed ID: 16800176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bullous pemphigoid in young patients: a retrospective study of 74 cases].
    Bourdon-Lanoy E; Roujeau JC; Joly P; Guillaume JC; Bernard P; Prost C; Tancrède-Bohin E; Delaporte E; Picard-Dahan C; Albes B; Bedane C; Doutre MS; Chosidow O; Lok C; Pauwels C; Chevrand-Breton J; Sassolas B; Richard MA
    Ann Dermatol Venereol; 2005 Feb; 132(2):115-22. PubMed ID: 15798559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-P 200 pemphigoid - The most common floor binding subepidermal autoimmune bullous disease in a tertiary care center in south India.
    Rai R; Anand JB; Shanmugasekar C; Arunprasath P; Chaitra V; Zillikens D; Schimdt E
    Indian J Dermatol Venereol Leprol; 2021; 87(6):787-791. PubMed ID: 34160166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral localized bullous pemphigoid in a young adult patient: A case report.
    Nourmohammadpour P; Akhdar M; Ghanadan A; Peymanfar AA; Saberi F; Keshavarz-Fathi M
    SAGE Open Med Case Rep; 2023; 11():2050313X231190730. PubMed ID: 37533489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid].
    Ambach A; Zillikens D; Klingert B; Hartmann AA; Burg G
    Hautarzt; 1992 Feb; 43(2):81-5. PubMed ID: 1548132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventions for bullous pemphigoid.
    Singh S; Kirtschig G; Anchan VN; Chi CC; Taghipour K; Boyle RJ; Murrell DF
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD002292. PubMed ID: 37572360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes.
    Kate A; Shanbhag S; Donthineni PR; Basu S
    F1000Res; 2021; 10():1201. PubMed ID: 35136583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical Bullous Pemphigoid After Linagliptin Intake.
    Dbouk S; Bazzi N; Saad WA; Toribio A; Habre M; Salloum A
    Am J Case Rep; 2021 Sep; 22():e932356. PubMed ID: 34584063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bullous pemphigoid presenting as generalized pruritus: observations in six patients.
    Alonso-Llamazares J; Rogers RS; Oursler JR; Calobrisi SD
    Int J Dermatol; 1998 Jul; 37(7):508-14. PubMed ID: 9679691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.